Neuland Laboratories Limited delivered exceptional quarterly results with consolidated net profit surging more than sevenfold to ₹213 crore from ₹28 crore in the same quarter last year. According to reports from CNBC TV18, the company's consolidated revenue grew 136% to ₹776.3 crore from ₹328.4 crore in Q4FY25, while EBITDA jumped to ₹307 crore from ₹51.1 crore. The most striking improvement came in operating margins, which expanded to 39.6% from 15.6% — representing a substantial 2,400-basis-point leap.
The quarterly results were significantly driven by robust export performance, particularly from key markets. As reported by CNBC TV18, revenue from the US and North America reached ₹313.7 crore in Q4 alone, more than three times the ₹99.6 crore recorded in the year-ago quarter. Europe similarly more than tripled to ₹296.6 crore from ₹95 crore, while domestic revenue grew more modestly to ₹121.5 crore from ₹100.6 crore. The sequential acceleration was also notable, with the March quarter showing approximately 76% higher revenue compared to the December quarter's ₹439.7 crore.
For the full financial year FY26, consolidated revenue rose 37% to ₹2,023 crore from ₹1,476.8 crore in FY25. According to the company's results, net profit came in at ₹364 crore against ₹260.1 crore a year earlier, representing approximately 40% growth. However, the FY25 figure included an exceptional gain of ₹76.4 crore from the perpetual lease transfer of an investment property in Nanakramguda, Hyderabad. Excluding this exceptional item, the underlying FY25 profit before tax was ₹269.9 crore, making the FY26 operating profit growth significantly stronger on a like-for-like basis.
The board announced significant capacity enhancement at the company's Unit 1 facility in Bonthapally Village, Sangareddy District, Telangana. As reported by CNBC TV18, the capacity will be expanded by 120.5 KL, representing a near 47% addition, at an investment of ₹143.4 crore (inclusive of GST). The expansion is expected to be completed within 12 to 18 months. The board also recommended a final dividend of ₹34 per equity share for FY26, subject to shareholder approval, with the record date set as July 24, 2026.
Despite the strong financial performance, shares of the company closed 2.56% lower at ₹17,100 ahead of the results announcement on Tuesday. According to CNBC TV18, this market reaction occurred before the official announcement of the quarterly results, suggesting investor expectations may have been higher than the actual performance delivered.
